R&D
더 나은 미래를 위해 SCM생명과학은 최선을 다할 것입니다.
성과
  • Human bone marrow-derived clonal mesenchymal stem cells decrease the initial C-reactive protein level in patients with moderately severe to severe acute pancreatitis
    Il Sang Shin, Chang-Hwan Park, Jong Ho Moon, Jun Kyu Lee, Don Haeng Lee, Min Jae Yang ; hcMSC working group on acute pancreatitis
    hcMSC working group on acute pancreatitis: Yun Nah Lee, Eunae Cho, Seok Jeong, Jin-Seok Park, Jin Hong Kim, Chang-Min Cho, Dong Wook Lee, Kyong Joo Lee, Dong Hee Koh, Joon Hyuk Choi, Jong Kyun Lee, Sang Soo Lee, Dong-Sik Ham, Ahrmi Cho
    Gastroenterology. 2023 Feb 17;S0016-5085(23)00143-9.
  • Clinically Relevant Mesenchymal Stem/Stromal Cell Sheet Transplantation Method for Kidney Disease
    Oka M, Kameishi S, Cho YK, Song SU, Grainger DW, Okano T.
    Tissue Eng Part C Methods. 2023 Feb;29(2):54-62. doi: 10.1089/ten.TEC.2022.0200.
1